ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RUA Rua Life Sciences Plc

11.375
0.25 (2.25%)
Last Updated: 08:24:24
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 2.25% 11.375 10.75 12.00 11.375 11.125 11.125 82,386 08:24:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.18M -2M -0.0323 -3.52 7.06M

AorTech International PLC Conversion of loan notes update (6467H)

02/12/2015 7:00am

UK Regulatory


Rua Life Sciences (LSE:RUA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Rua Life Sciences Charts.

TIDMAOR

RNS Number : 6467H

AorTech International PLC

02 December 2015

AorTech International plc

(the "Company")

Conversion of loan notes update

The Company announced on 26 October 2012 that it had issued secured loan notes (the "Loan Notes"). The Loan Notes were redeemed on 1 February 2013, but the Loan Note holders retained the right to receive from the Company on a change of control payment of a sum equal to 15% of the aggregate sums to shareholders. At the Annual General Meeting held on 24 September 2015 shareholder approval was obtained for the Board to take all necessary steps to allow the Company to allot shares in exchange for the surrender of these rights. The Company has now called a general meeting for the Loan Note holders on 21 December 2015 at which they are proposing to allot an aggregate of 724,917 new ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") (representing 15% of the existing issued share capital of the Company) in exchange for the surrender of all remaining rights under the Loan Notes.

The Company has received sufficient irrevocable commitments to ensure that the resolution will be passed.

Application has been made for 724,917 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 22 December 2015. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

Both Eddie McDaid and Bill Brown were Loan Note holders and will be issued 47,928 and 11,982 shares respectively. Their resultant holdings will be:

 
                 Ordinary shares   % holding 
 
  Eddie McDaid       406,842         7.32 
    Bill Brown       12,389          0.22 
 

The total number of Ordinary Shares in issue following Admission will be 5,557,695. Accordingly, the figure of 5,557,695 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

This information is provided by RNS

For further information contact:

AorTech International plc

Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869

AorTech International plc

Bill Brown, Chairman Tel: +44 (0)7730 718296

finnCap Limited

   Jonny Franklin-Adams/ Giles Rolls                                             Tel: +44 20 7220 0500 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUGGCPPUPAGMG

(END) Dow Jones Newswires

December 02, 2015 02:00 ET (07:00 GMT)

1 Year Rua Life Sciences Chart

1 Year Rua Life Sciences Chart

1 Month Rua Life Sciences Chart

1 Month Rua Life Sciences Chart

Your Recent History

Delayed Upgrade Clock